✨ Meet us at Music City SCALE 2026 in Nashville!
Stratpharma Switzerland is proud to be part of the Symposium for Cosmetic Advances & Laser Education!
📆 May 14-16, 2026
📍 Grand Hyatt Nashville
🛎️ Visit us at Booth 208
San Diego, California Oct 20, 2023 (The content of this article comes exclusively from the website Issuewire.com) Stratpharma AG, a Swiss-based global leader specializing in innovative topical medical devices for enhancing Oncology Supportive Care, Dermatology, Plastic Surgery, Wound Care and Women’s Health, today announced the appointment of Jeff Wellman as the Chief Commercial Officer for…
Stratpharma Inc. (USA) donated $8’000 to the Kruz’n For a Kure Foundation which searches for a cure for the Schimke immuno-osseous dysplasia, a fatal form of dwarfism characterized by short stature, kidney disease, and a weakened immune system Alexis Jammo, our Regional Sales Manager had the chance to meet the Davenport’s with their two children…
Let’s connect at ONS 2026 in San Antonio! Stratpharma is pleased to participate in the Oncology Nursing Society (ONS) Congress 🎉 🗓 Date: 14-16 May📍Location: San Antonio, Texas🎯 Visit us at Booth: 230 We look forward to meeting oncology professionals and sharing our latest topical innovations in radiotherapy and oncology supportive care.
The Cosmetic Surgery Forum recently asked some of their top Key Opinion Leaders in the industry to share their Top 5 Vendors with whom they work with, who have brought significant value to their business and patient experience. From “help managing changes in coding regulations to device companies whose work and research have meaningfully impacted…
Stratpharma’s innovative film-forming wound dressing STRATAMED has been nominated as Best Post-Surgery Product of the Year of My Face My Body Awards 2018! The competition of the My Face My Body Awards may be fierce but we here at Stratpharma are convinced that Stratamed has a good chance of winning this award. Stratamed is a…
May is skin cancer awareness month. Worldwide every year between 2 to 3 million people are diagnosed with non-melanoma skin cancer and 132’000 with melanoma. One in every three cancers diagnosed is a skin cancer which makes it the most common type of cancer.¹ In the US the likelihood to develop skin cancer is noticeably…